newsfilter
← Latest News
PR Newswire·

Decoy Therapeutics Announces 1-for-12 Reverse Stock Split

Decoy Therapeutics Inc. (NASDAQ: DCOY), a preclinical-stage biopharmaceutical company that is engineering the next generation of peptide conjugate...